33 filings
8-K
XLO
Xilio Therapeutics Inc
17 Jun 24
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
XLO
Xilio Therapeutics Inc
13 Jun 24
Departure of Directors or Certain Officers
4:15pm
8-K
XLO
Xilio Therapeutics Inc
14 May 24
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
7:45am
8-K
XLO
Xilio Therapeutics Inc
1 Apr 24
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
4:15pm
8-K
XLO
Xilio Therapeutics Inc
28 Mar 24
Other Events
4:08pm
8-K
1sxlwezv16ayv
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
io93hhln4k
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
vlko8z1s5mabbdi8o
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
8-K
3b92j
7 Dec 23
Other Events
7:45am
8-K
vx1 0g0tq8rybl4
9 Nov 23
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
4:13pm
8-K
h0tfm7 9rqtli
3 Nov 23
Other Events
4:05pm
8-K
a8uho6e4
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
xohbq7y7u ecn6klhnv
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
bi7996agsbpbp0t8f3
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
4rj8d fwjndc
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
fmk1xqshhlc
25 May 23
Regulation FD Disclosure
5:05pm
8-K
tq9647tx7g rvsj9
9 May 23
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
7:45am
8-K
pxb 456rg
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
aj5r6y pg
2 Mar 23
Xilio Therapeutics Announces Pipeline and Business Updates for the Fourth Quarter and Full Year 2022 Financial Results
4:16pm
8-K
dv89w5s 794omjxmvzun
9 Jan 23
Regulation FD Disclosure
8:30am